Gil M. Labrucherie - 15 Nov 2021 Form 4/A - Amendment Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role: SVP, COO & CFO
Signature: Mark A. Wilson, Attorney-in-Fact
Issuer symbol: NKTR
Transactions as of: 15 Nov 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 20 Dec 2021, 19:22:22 UTC
Date Of Original Report: 17 Nov 2021
Previous filing: 14 Oct 2021
Next filing: 18 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NKTR	Common Stock						280,381	15 Nov 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The original Form 4, filed on November 17, 2021, is being amended by this Form 4 amendment solely to correct a clerical error, which misreported the amount of securities beneficially owned by the reporting person following the reported transaction as 280,831 when in fact it was 280,381. All other information in the original Form 4 remains the same. This amendment shall also be deemed to correct the total beneficial ownership reported by the reporting person in subsequently filed Forms 4 filed prior to the date hereof.